15 states sue Trump administration over childhood vaccines

News brief
gavel
iStockphoto

Attorneys general from 14 states led by Democrats and the governor of Pennsylvania sued the Trump administration today over recent changes to the recommended childhood vaccine schedule.

The lawsuit names Health and Human Services and Health (HHS) Secretary Robert F. Kennedy Jr. and Centers for Disease Control and Prevention (CDC) Acting Director Jay Bhattacharya, MD, PhD as defendants, and asks the courts to nullify the administration’s decision to reduce the childhood vaccine schedule. The vaccine schedule previously recommended immunizing against 17 diseases, but in January the CDC moved to recommending against only 11.

Attorneys general from Arizona, California, Colorado, Connecticut, Delaware, Maine, Maryland, Michigan, Minnesota, New Jersey, New Mexico, Oregon, Rhode Island, and Wisconsin, as well as Pennsylvania Governor Josh Shapiro, are the plaintiffs.

Second major lawsuit against HHS

The stated goal of HHS’s changes is to move the United States toward Denmark’s model of childhood immunization.

“Copying Denmark’s vaccine schedule without copying Denmark’s health care system doesn’t give families more options — it just leaves kids unprotected from serious diseases,” said Kris Mayes, attorney general of Arizona, at a press conference yesterday.

This is the second major lawsuit against Kennedy in the past year. In July six medical societies sued HHS after the agency said it was no longer recommending routine COVID-19 vaccines for many groups, including pregnant woman. 

Innovative antibiotic candidate gets funding boost

News brief
Topics
Antimicrobial Stewardship

British immunotherapy company Centauri Therapeutics yesterday announced a ₤6 million ($8.1 million USD) investment from the AMR Action Fund to support development of its broad-spectrum antibiotic candidate.

The money will help support the completion of phase 1 clinical studies for CTX-187, a novel antibiotic that employs a dual-mechanism action to target clinically prevalent and multidrug-resistant gram-negative bacteria. The drug is built on Centauri's Alphamer platform, which harnesses the immune system to target pathogenic bacteria.

The investment from AMR Action Fund, a venture capital fund focused on development of novel antimicrobial therapeutics for priority pathogens, is part of a ₤30 million ($40.6 million USD) funding round secured by Centauri.

"This latest investment has enabled us a clear path to progress CTX-187 beyond Phase I trials and onto the development of a Phase II-ready asset," Centauri CEO Jennifer Schneider, PhD, MPH, said in a press release. "I would like to thank the AMR Action Fund, as well as all of our existing investors and collaborators, for their support."

Aim is to invest $1 billion

Centauri is the 12th company to receive funding from the AMR Action Fund, which was launched in 2020 with the aim of investing $1 billion in small and mid-sized biotech companies with promising antimicrobial products.

"The growing burden of drug-resistant Gram-negative infections is one of the most pressing challenges in global health, leaving patients with limited and increasingly ineffective treatment options," said AMR Action Fund CEO Henry Skinner, PhD. "Centauri’s approach represents a promising opportunity to address this challenge, and we are pleased to support the team as they advance toward first-in-human studies." 

This week's top reads

  1. Recent pandemic viruses, including SAR-CoV-2, spread directly to people without adaptation, researchers say

    The findings provide further evidence against the COVID-19 lab-leak hypothesis.

    Mary Van Beusekom
    Mutation

  2. US measles total approaches 1,300 infections

    The CDC notes that Texas has now recorded 93 cases this year after having the nation's largest outbreak last year.

    Jim Wappes

  3. Babies with COVID-19 develop more serious disease than those with RSV, US data reveal

    Children under 2 hospitalized for COVID-19 are more likely to die or become seriously ill than babies with RSV, according to a new study.

     

    Liz Szabo
    A newborn in the intensive care unit.

  4. FDA vaccine advisers recommend adding subclade K to fall shots

    Although the US officially left the WHO in January, US scientists continue to collaborate with international researchers to track the evolution of flu viruses.

    Liz Szabo
    Exterior shot of FDA building.

  5. FDA vaccine advisers to meet to recommend strains for fall flu shots

    For the first since the Biden administration, vaccine advisers will meet tomorrow to recommend which strains of influenza virus to include in flu vaccines this fall.

    Liz Szabo
    A photo of the front of the Food and Drug Administration building in Silver Spring, Maryland.

  6. Measles outbreaks slow in South Carolina, Arizona, but Utah sees cases skyrocket past 400

    Earlier this week, the CDC reaffirmed its commitment to the South Carolina Department of Public Health.

    Stephanie Soucheray
    measles rash on arm

  7. CDC reports 11 more pediatric flu deaths

    A total of 90 US children have died from flu-related complications this season, according to the latest CDC update.

    Chris Dall

  8. Avian flu detected at 20 commercial poultry operations

    Two live bird markets, 1 in Orange County, Florida, and 1 in Kings County, New York, reported bird flu outbreaks.

    Stephanie Soucheray

  9. The State of US Vaccine Policy — Mar 5, 2026

    Since our last update, 14 states have filed vaccine lawsuits, the CDC lost its 2 most senior officials in rapid succession, a surgeon general nominee couldn't bring herself to recommend the measles vaccine, and more.

    Jess Steier, DrPH, Izzy Brandstetter Figueroa, MPH
    Gloved hand vaccine vial

  10. Vaccine Integrity Project kicks off evidence review of Tdap vaccine in pregnancy

    Experts say they expect the findings to show how effectively the vaccine reduces pertussis infections, hospitalizations, and deaths among infants.

    Mary Van Beusekom
    Mom holding infant

Our underwriters